significant (HR of heavy users, 1.50; 95% CI,), but a longer duration of PPI use was associated with mild renal progression in patients less than 65 years old (HR of heavy users, 2.24; 95% CI, 1.09-4.60). CONCLUSIONS: Our results suggested that PPI use increased the risk of AKI development. In younger patients, PPI use was more significantly associated with acute and chronic renal injuries. 
INTRODUCTION AND AIMS:
The carotid-femoral pulse wave velocity (cfPWV) is a noninvasive method to evaluate central arterial stiffness and is associated with future cardiovascular disease and all-cause mortality. Osteopontin (OPN) was recognized as a significant participant in the atherosclerotic inflammatory mediator. We evaluated the association between serum OPN levels and central arterial stiffness in patients with hemodialysis (HD). METHODS: A total of 126 patients with HD were enrolled in this study. cfPWV value was measured by a validated tonometry system (SphygmoCor). Patients with cfPWV >10 m/s were used to define the high central arterial stiffness group, while values &#8804; 10 m/s were regarded as the low central arterial stiffness group, according to the ESH-ESC 2013. Serum OPN levels were measured using a commercial enzymelinked immunosorbent assay kit. RESULTS: Fifty-three patients (42.1%) had high central arterial stiffness and higher percentages of diabetes (P ¼ 0.001), hypertension (P ¼ 0.022), were of older age (P ¼ 0.007) and had higher systolic blood pressure (P ¼ 0.045), total calcium level (P ¼ 0.044) and OPN levels (P < 0.001) compared to subjects with low central arterial stiffness. After adjusting for factors significantly associated with central arterial stiffness by multivariate logistic regression analysis revealed that OPN levels (odds ratio (OR): 1.095, 95% confidence interval (CI): 1.041-1.152, P ¼ 0.006), age (OR: 1.068, 95% CI: 1.026-1.112, P ¼ 0.001), diabetes (OR: 6.564, 95% CI: 2.293-18.792, P < 0.001), and serum total calcium level (OR: 2.503, 95% CI: 1.114-3.784, P ¼ 0.021) were the independent predictors of central arterial stiffness in HD patients. Multivariate forward stepwise linear regression analysis also showed that logarithmically transformed OPN level (log-OPN, b ¼ 0.255, P ¼ 0.002) was an independent predictor of cfPWV values in HD patients. The area under the receiver-operating characteristic (ROC) curve predicting central arterial stiffness by log-OPN level in HD patients was 0.708 (95% CI: 0.621-0.786, P < 0.001). CONCLUSIONS: In this study, high serum OPN level was positively associated with cfPWV values and thus was related to high central arterial stiffness in HD patients. 
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INTRODUCTION AND AIMS:
Renal function impairment has been known to be involved in a higher incidence of malignancies. However, there is no study investigating the relative incidence rate of specific types of digestive cancer in patients with pre-dialytic chronic kidney disease (CKD) compared to the general population. METHODS: Using data from the National Health Insurance Service-National Sample Cohort in the Republic of Korea, this study was conducted on newly-diagnosed predialytic CKD patients (n¼35,547). We compared the standardized incidence rate (SIR) of digestive cancer between the cohort and national data from the National Cancer Registry. RESULTS: During the median follow-up of 54.9 months, an incidence risk of digestive cancer in CKD patients was significantly higher than the general population [SIR; 1.54, 95% confidence interval (CI); 1.46-1.62]. Additionally, the SIRs of hepatoma [SIR; 5.88, 95% CI; 1.52-10.23] and colorectal cancer [SIR; 4.51, 95% CI; 1.56-7.45] were remarkably greater in CKD patients younger than 40 years. However, the incidence risk of specific types of digestive cancer seemed to be similar irrespective of sex except for bile duct and gall bladder cancer. In addition, when those patients were stratified into two groups based on the part of the year 2008 in which CKD was diagnosed, the SIRs exhibited similar trends irrespective of the CKD-diagnosed time-point. CONCLUSIONS: This study showed that CKD is associated with an increased risk of digestive cancer incidence compared to the general population. Moreover, the SIRs of hepatoma and colorectal cancer were exceptionally higher in CKD patients younger than 40 years. 
FP114 BIOPSY PROVEN RENAL DISEASES OF PREGNANCY & THEIR EFFECTS ON FETOMATERNAL OUTCOMES
INTRODUCTION AND AIMS:
Kidney biopsy is the golden standard for renal disease diagnosis and treatment. Nevertheless, in older subjects risk and clinical outcomes are dependent from a combination of biological, functional, psychological, and environmental factors. Tools that effectively identify patients with different life expectancies should be multidimensional. A Multidimensional Prognostic Index (MPI) for 1-year mortality derived from a standardized Comprehensive Geriatric Assessment (CGA) was developed for this purpose. No data are available regarding the association between frailty index and clinical outcomes in elderly subjects undergoing kidney biopsy. Aim of this study was to evaluate the usefulness of MPI for predicting mortality, treatment failure and requirement of chronic dialysis in elderly patients after renal biopsy. METHODS: Biopsy and clinical data from 67 patients aged 65 years were retrospectively collected revising renal biopsies performed in our department from January 2015 to June 2017. Follow-up period was at least 6 months. Patients were stratified at the time of renal biopsy according to both age (65-74 years; 75 years) and MPI (lowfrailty: MPI-1; medium-frailty: MPI-2; high-frailty: MPI-3). Clinical outcomes were death from any cause, response to therapy, need of chronic RRT, biopsy-related complications and therapy-related complications. Data are reported as mean6SD and ttest or ANOVA have been used to compare groups. RESULTS: Cohort consisted of 67 patients, 30 women (44.8%) and 37 men (55.2%), mean age was 7566,2 years. Neither biopsy-related complications nor therapy-related complications were observed in the cohort studied. Death was more frequent in older patients ranging from low-frailty to high-frailty patients ( with MPI-1 (MPI 1¼8.8 %, MPI 2¼25.9%), being 100% in patients with MPI 3 (p<0.05). The frequency of treatment failure was similar in the two age groups (41.9% in 65-74 years vs 44.4% in over 75), but it increased according to frailty grading (MPI-1¼44,1%, MPI-2¼63%, MPI-3¼100%; p<0,05). According to the age stratification, no differences were observed in the percentage of patients requiring chronic dialysis; by contrast, patients with higher MPI showed higher probability to continue dialytic treatment (MPI-1¼14.7%, MPI-2¼ 44.4%, MPI-3¼66.7%; p<0,05). Data are summarized in Figure1. CONCLUSIONS: Kidney biopsy and related treatment are safe in the elderly. Clinical outcomes are not depending on age at the biopsy, while frailty index might better identify patients with worst outcome in terms of treatment failure and need of chronic dialysis. In conclusion, MPI could be considered a useful tool to identify patients at higher risk helping clinicians in evaluating risks and benefits of the diagnostic procedure. (1978) (1979) (1980) (1981) (1982) (1983) (1984) (1985) (1986) (1987) (1988) (1989) (1990) (1991) (1992) (1993) (1994) (1995) (1996) (1997) and the second one (1998) (1999) (2000) (2001) (2002) (2003) (2004) (2005) (2006) (2007) (2008) (2009) (2010) (2011) (2012) (2013) (2014) (2015) (2016) (2017) . Patients were classified by the place of living (A-endemic areas, B-hypoendemic, C-non -endemic urban, D-non-endemic rural regions).Finally, we jointly observed groups C and D (non-endemic areas) for MTUU and MTUB. RESULTS: From 1987 to 2017, 1314 cases of MTU were registered: 106 (8.07%) of MTUU and 1208 (91.93%) of MTUB. Totally of 981 tumor cases (74.66%) appeared in males, and 333 (25.34 %) appeared in females. The incidence of MTU regarding gender showed insignificant sex differences of MTUU (55 males vs 51 females) and very significant differences of MTUB (males to females ratio was 3.28:1). Average Annual Incidence Rate (AAIR) was 12.88 for MTUU and 11.84 for MTUB. There were a 2.31 (74:32 cases) times fall in relative incidence of MTUU per annum from first (1978) (1979) (1980) (1981) (1982) (1983) (1984) (1985) (1986) (1987) (1988) (1989) (1990) (1991) (1992) (1993) (1994) (1995) (1996) (1997) to second (1998) (1999) (2000) (2001) (2002) (2003) (2004) (2005) (2006) (2007) (2008) (2009) (2010) (2011) (2012) (2013) (2014) (2015) (2016) (2017) period, while the approximate annual rate for MTUB in the concerned period increased by 3.19 times (288:920). AAIR of MTUU was 11.82 in the endemic settlements. The rate was considerably lower in hypoendemic (4.49), nonendemic urban (0.82) and non-endemic rural settlements (0.84). Regarding the incidence of MTUB, our research showed the highest AAIR in patients from endemic areas (14.35), while 11.23 in hypo-endemic and 11.82 in non-endemic regions. Comparing MTUU and MTUB we noted insignificant differences within A group (11.82 vs. 14.35,p > 0.05), and very significant difference within D group (0.84 vs. 11.82,p < 0.01). There was five times decline in the relative rate of incidence of MTUU per annum in endemic settlements from the first to the second period, while the approximate annual rate for MTUU in nonendemic regions is increased by 1.93 times (54:28). The decline of MTUU per annum in endemic settlements of Jablanica region in both researched periods is equal with the decline of BEN incidence. The linear trend of BEN incidence was in statistical decline. In addition, the linear trend of MTUU is decreasing (Grafik 1), while the linear trend of MTUB is in an increase (Grafik 2). CONCLUSIONS: High frequency of MTU, primarily MTUU in the areas with BEN incidence, probably points to the common nephropathogenic and cancerogenic etiologic factors and proves the existence of a positive correlation between BEN and MTUU. 
FP117 COMPARISONS OF DIFFERENT EQUATIONS FOR
